PROTEOMICS · 2018 · 89 citations · 37 references
Life SciencesBiochemistryEndocrinologyGestational DiabetesMaternal-fetal MedicineProteomicsExosome AnalysisGestational Diabetes MellitusMass Spectrometry-based ProteomicsPlacental PhysiologyProteomic BiomarkersProteomic ProfilingExosomal BiomarkersExosomal Protein AnalysisExosome CharacterizationExosome Protein BiomarkersExosome ProteomicsExosomesImpaired Glucose TolerancePlacental Proteomics
Several factors including placental hormones (PH) released from the human placenta have been associated with the development of insulin resistance and gestational diabetes mellitus (GDM). However, circulating levels of PH does not correlate well with maternal insulin sensitivity across gestation, suggesting that other, previously unrecognized, mechanisms may be involved. The levels of circulating exosomes are higher in GDM compared to normal. GDM derived exosomes produce greater release of pro-inflammatory cytokines from endothelial cells compared to exosomes from normal, suggesting that their contents may differ compared to normal pregnancies. Using a quantitative, information-independent acquisition (Sequential Windowed Acquisition of All Theoretical Mass Spectra [SWATH]) approach, differentially abundant circulating exosome proteins are identified in women with normal glucose tolerance (NGT) and GDM at the time of GDM diagnosis. A total of 78 statistically significant proteins in the relative expression of exosomal proteins in GDM are compared with NGT. Bioinformatic analysis shows that the exosomal proteins in GDM target pathways are mainly associated with energy production, inflammation, and metabolism. Finally, an independent cohort of patients is used to validate some of the proteins identified by SWATH. The data obtained may be of utility in elucidating the underlying physiological mechanisms associated with insulin resistance in GDM.
37
Lorraine Dugoff, John C. Hobbins, Fergal D. Malone et al. · American Journal of Obstetrics and Gynecology · 2004 · 621 citations